During the World's Prostate Month, doctors in Delhi hail the multi-use HOLEP technology
September is being celebrated as World's Prostate Month. Prostate is a walnut-sized male reproductive gland located at the base of urinary bladder surrounding the urethra. In a normal adult, it weighs around 20 g. Its size increases slowly with age, which is known as benign prostatic hyperplasia (BPH) or lower urinary tract symptoms (LUTS).
This condition is very common in elderly males above 50 years. BPH is a non-cancerous enlargement and it does not even increase the risk for prostate cancer. But the enlarged prostate squeezes the urethra causing difficult and painful urination. In severe cases, urination may become impossible, which requires immediate attention. Symptoms of enlarged prostate include frequent urination, urgency, hesitancy (weak stream), urge even after urination, and blood in urine.
HOLEP (Holmium Laser Enucleation of Prostate) is among the new technology being introduced for the treatment. As per the data provided by the RG Stone Urology and Laparoscopy Hospital, they have treated more than 10,000 cases of prostate in a year through this procedure. Apparently, they are also the only one across Asia to solve over 10,000 successful laser prostatectomies.
"Prostatectomy is the surgical removal of all or part of the prostate gland. A variety of lasers have been developed to treat Benign Prostatic Hyperplasia (BPH). Each laser has its own unique optical distinctiveness that has resulted in considerably dissimilar clinical outcomes. HOLEP, apart from prostate removal, can effectively be used to treat the largest of glands with minimal morbidity. It completely removes the prostate lobes with immediate resolution of the obstruction," said Dr B S Bansal, chairman and managing director, RG Stone Urology and Laparoscopy Hospital.
The data also shows that people with various other problems have also been treated with this technology. It says 64 per cent cases with Diabetes Mellitus, 58 per cent cases with Hypertension, 37 per cent cases with old M.I, 12 per cent cases with CVA+ hemiparesis, 26 per cent with COAD, 7 per cent with bundle branch blocks, 2 per cent on anticoagulants and 0.4 per cent with cardiac pacemaker cases have been also treated.
"HOLEP has various other advantages over other available technologies such as standard transurethral resection of prostate (TURP), including technical simplicity and the absence or minimisation of complications. It also promises shorter hospital stay and faster recovery," said Dr Harbans Singh, Chief Urologist, RG Stone.